Bioequivalence Study of Paricalcitol Capsules, 4 mcg Under Fasting Conditions
Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
An open-label, balanced, randomized, two-treatment, two-sequence, two-period, single-dose,
crossover oral bioequivalence study in healthy subjects under fasting conditions.